Ftse Mib
33.273,12
0,55%
DAX
19.425,73
0,85%
S&P 500
5.998,74
-0,38%
NASDAQ
19.060,48
-0,60%
Bitcoin
94.867,05
-1,16%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Portage Biotech Inc (PRTG) Portage Biotech Inc (PRTG) Notizie

Portage Biotech Inc

PRTG
4,29
-0,58 (-11,91%)
28 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/11/202422:47EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
26/11/202422:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/11/202422:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/11/202422:05GLOBEPortage Biotech Reports Results for Fiscal Quarter Ended..
14/11/202422:26EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
04/10/202422:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/10/202422:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202403:18EDGAR2Form 144 - Report of proposed sale of securities
27/9/202422:28EDGAR2Form 144 - Report of proposed sale of securities
23/9/202415:41EDGAR2Form 144 - Report of proposed sale of securities
20/9/202417:25EDGAR2Form 144 - Report of proposed sale of securities
28/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
27/8/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/8/202414:00GLOBEPortage Biotech Reports Results for Fiscal Quarter Ended..
27/8/202412:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/8/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202414:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202413:00GLOBEPortage Biotech Reports Fiscal Year-Ended March 31, 2024..
14/8/202423:29EDGAR2Form 20-F - Annual and transition report of foreign private..
13/8/202414:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/8/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/8/202413:00GLOBEPortage Biotech Announces 1-for-20 Reverse Stock Split
01/8/202422:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/4/202414:01GLOBEPortage Biotech Announces Plans to Expand its Evaluation of..
26/3/202413:01GLOBEPortage Biotech Completes Monetization of Intensity..
08/3/202423:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/3/202423:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/2/202423:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202423:10GLOBEPortage Biotech Reports Results for Fiscal Quarter Ended..
18/1/202423:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/1/202414:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/1/202414:00GLOBEPortage Biotech Reports Business and Strategic Update
01/12/202322:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
Apertura: 4,90 Min: 4,2001 Max: 4,99
Chiusura: 4,87

La tua Cronologia

NASDAQ
PRTG
Portage Biotech
AQSE
FNK
Fenikso
BIT
WDHE
Invesco S&P World Health...
BIT
S5SWTI
Sg Issuer
TG
A3LUHZ
Danske Bank AS
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network